BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12882972)

  • 21. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
    Mikael LG; Genest J; Rozen R
    Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.
    Zannis VI; Chroni A; Kypreos KE; Kan HY; Cesar TB; Zanni EE; Kardassis D
    Curr Opin Lipidol; 2004 Apr; 15(2):151-66. PubMed ID: 15017358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
    Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; FiƩvet C; Wright SD; Staels B
    J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice.
    Masson D; Qatanani M; Sberna AL; Xiao R; Pais de Barros JP; Grober J; Deckert V; Athias A; Gambert P; Lagrost L; Moore DD; Assem M
    J Lipid Res; 2008 Aug; 49(8):1682-91. PubMed ID: 18441373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein.
    Tu AY; Albers JJ
    Diabetes; 2001 Aug; 50(8):1851-6. PubMed ID: 11473048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
    Singaraja RR; Bocher V; James ER; Clee SM; Zhang LH; Leavitt BR; Tan B; Brooks-Wilson A; Kwok A; Bissada N; Yang YZ; Liu G; Tafuri SR; Fievet C; Wellington CL; Staels B; Hayden MR
    J Biol Chem; 2001 Sep; 276(36):33969-79. PubMed ID: 11423537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.
    Black LL; Srivastava R; Schoeb TR; Moore RD; Barnes S; Kabarowski JH
    J Immunol; 2015 Nov; 195(10):4685-98. PubMed ID: 26466956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of expression of apolipoprotein A-I by selenium status in human liver hepatoblastoma cells.
    Stahle JA; Vunta H; Channa Reddy C; Sandeep Prabhu K
    Eur J Nutr; 2009 Aug; 48(5):283-90. PubMed ID: 19294445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression.
    Gentili C; Tutolo G; Pianezzi A; Cancedda R; Descalzi Cancedda F
    Matrix Biol; 2005 Feb; 24(1):35-44. PubMed ID: 15749000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes.
    Wu ZH; Zhao SP
    Pharmacology; 2009; 84(5):282-7. PubMed ID: 19797938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the differential expression of lipid metabolism-related genes in young LDLR knockout mice liver].
    Shang YJ; Dai XD; Jing W; Du HQ; Ye HY; Yin M; Zhang L; Zhang SQ; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):179-83. PubMed ID: 18788595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
    Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
    J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.
    Bhalla S; Ozalp C; Fang S; Xiang L; Kemper JK
    J Biol Chem; 2004 Oct; 279(43):45139-47. PubMed ID: 15322103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.